These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 20075667)

  • 21. Psychotherapeutic benefits of opioid agonist therapy.
    Tenore PL
    J Addict Dis; 2008; 27(3):49-65. PubMed ID: 18956529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
    Trémeau F; Darreye A; Leroy B; Renckly V; Ertlé S; Weibel H; Khidichian F; Macher JP
    Encephale; 2003; 29(4 Pt 1):285-92. PubMed ID: 14615698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psychiatric disorders associated with high-dose methadone (>100 mg/d): a retrospective analysis of treated patients].
    Eiden C; Leglise Y; Clarivet B; Blayac JP; Peyrière H
    Therapie; 2012; 67(3):223-30. PubMed ID: 22874488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone treatment.
    Rashiq S
    CMAJ; 1999 Nov; 161(10):1241. PubMed ID: 10584081
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute physical dependence in man: repeated naloxone-precipitated withdrawal after a single dose of methadone.
    Wright C; Bigelow GE; Stitzer ML
    NIDA Res Monogr; 1989; 95():395-6. PubMed ID: 2701308
    [No Abstract]   [Full Text] [Related]  

  • 28. The first 38 methadone maintenance treatment patients in Stockholm: 15-year follow-up with a main focus on detoxification from methadone.
    Hiltunen AJ; Eklund C; Borg S
    Nord J Psychiatry; 2011 Apr; 65(2):106-11. PubMed ID: 20662685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 30. [Depressive disorders in management of drug dependent patients. Methadone maintenance].
    Laqueille X; Spadone C
    Encephale; 1995 Dec; 21 Spec No 4():11-4. PubMed ID: 8808339
    [No Abstract]   [Full Text] [Related]  

  • 31. Alterations in methadone metabolism during late pregnancy.
    Jarvis MA; Wu-Pong S; Kniseley JS; Schnoll SH
    J Addict Dis; 1999; 18(4):51-61. PubMed ID: 10631963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moderate- vs high-dose methadone for opioid dependence.
    Grabowski J; Creson D; Rhoades HM; Schmitz JM
    JAMA; 1999 Dec; 282(22):2121-2; author reply 2122-3. PubMed ID: 10591329
    [No Abstract]   [Full Text] [Related]  

  • 33. Diphenoxylate hydrochloride dependency.
    Firoozabadi A; Mowla A; Farashbandi H; Gorman JM
    J Psychiatr Pract; 2007 Jul; 13(4):278-80. PubMed ID: 17667743
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comment to a contribution on methadone program in Stockholm].
    Eriksson N
    Lakartidningen; 2001 Dec; 98(50):5797. PubMed ID: 11789109
    [No Abstract]   [Full Text] [Related]  

  • 35. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
    Hermann D; Klages E; Welzel H; Mann K; Croissant B
    Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing the effectiveness of methadone using psychotherapeutic interventions.
    O'Brien CP; Woody GE; McLellan AT
    NIDA Res Monogr; 1995; 150():5-18. PubMed ID: 8742769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of opioid withdrawal].
    Shaygani S; Waal H
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):114-5. PubMed ID: 19151804
    [No Abstract]   [Full Text] [Related]  

  • 40. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.